CGNX
Cognex Corporation
CGNX has the edge over SNDK overall, supported by lower modeled downside and stronger valuation.
SNDK
Sandisk Corporation
SNDK's outlook is improving, though it still trails on the overall score.
CGNX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CGNX's revenue, profitability, cash flow and balance sheet are all currently healthy.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
CGNX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 26x | $50.77 | — |
| Current | 35x | $50.77 | — |
| Cheap | 40x | $57.69 | +14% |
| Fair | 55x | $79.70 | +57% |
| Expensive | 79x | $113 | +123% |
Historical ranges are pointers, not guarantees.
CGNX's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 26x next year's earnings.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over CGNX in the historical PE scenario, which offers more potential upside but is not a forecast.
CGNX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CGNX, with profitability improving.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
CGNX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.94 | +35% |
| Q3 2026 | $1.44 | +122% |
| Q2 2026 | $1.04 | +44% |
| Q1 2026 | $0.85 | +23% |
| Q4 2025 | $0.68 | +9.7% |
| Q3 2025 | $0.65 | +27% |
| Q2 2025 | $0.72 | +60% |
| Q1 2025 | $0.69 | +21% |
| Q4 2024 | $0.62 | -4.6% |
CGNX earned $1.44 per share over the past year, up 122% from the year before.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over CGNX in the latest year-over-year earnings comparison.
CGNX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $313.4M | +13% |
| Q2 2026 | $291.3M | +17% |
| Q1 2026 | $268.4M | +24% |
| Q4 2025 | $252.3M | +9.9% |
| Q3 2025 | $276.9M | +18% |
| Q2 2025 | $249.1M | +4.1% |
| Q1 2025 | $216M | +2.5% |
| Q4 2024 | $229.7M | +17% |
CGNX's revenue has grown year over year for nine quarters in a row: $313M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | +11 points |
| Q2 2026 | 29% | +12 points |
| Q1 2026 | 22% | +10 points |
| Q4 2025 | 14% | +0.6 points |
| Q3 2025 | 21% | +7.4 points |
| Q2 2025 | 17% | +1.4 points |
| Q1 2025 | 12% | +5.3 points |
| Q4 2024 | 13% | +7 points |
CGNX's operating margin was 32% last quarter, up 11 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK's revenue has grown year over year for six quarters in a row: $11B last quarter, up 378% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over CGNX on profitability, with a higher operating margin.
CGNX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $103.8M | +21% |
| Q2 2026 | $67.6M | +67% |
| Q1 2026 | $42.3M | +11% |
| Q4 2025 | $72.3M | +47% |
| Q3 2025 | $86M | +66% |
| Q2 2025 | $40.4M | +74% |
| Q1 2025 | $38M | +297% |
| Q4 2024 | $49.3M | +560% |
CGNX has the edge over SNDK on cash flow, with more consistent year-over-year improvement.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK generated $17.4B in free cash flow over the past year, more than ten times what it generated the year before.
CGNX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +1M shares |
| 1 year | +1% | +1.7M shares |
| 3 years | -1.3% | -2.3M shares |
| 5 years | -5.2% | -9.3M shares |
| Available history | -2.4% | -4.2M shares |
CGNX has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $6.2M |
| Q1 2026 | $99M |
| Q4 2025 | $25M |
| Q3 2025 | $24M |
| Q2 2025 | — |
| Q1 2025 | $102.2M |
| Q4 2024 | $43.2M |
CGNX spent $130M buying back its own shares over the past year, down 23% from the year before.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CGNX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.2x | Net Cash |
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -1.3x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -1.3x | Net Cash |
CGNX has the edge over SNDK on leverage, with a lower net debt burden relative to earnings.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
CGNX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.1 | Neutral |
| Stochastic | 13.4 | Oversold |
CGNX's weekly RSI is 41 (neutral) and its Stochastic is 13 (oversold).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
CGNX PE vs Technology Sector
| Metric | CGNX | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 28x | 27% above |
| PE % | 8 | 35 | 27 pts below |
CGNX is trading at 35x earnings, a 27% premium to the Technology sector's median of 28x.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over CGNX on valuation relative to its sector.
CGNX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $56.4 | 9.9% below |
| 20 week MA | $60.9 | 17% below |
| 50 week MA | $55.1 | 7.8% below |
| 100 week MA | $45.6 | 11% above |
| 200 week MA | $44.9 | 13% above |
CGNX has stronger trend alignment. CGNX is above 2 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
CGNX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $56.2 | $80.7 | +44% |
| 2021 | $80.7 | $77.6 | -3.9% |
| 2022 | $77.6 | $47.4 | -39% |
| 2023 | $47.4 | $41.7 | -12% |
| 2024 | $41.7 | $36.0 | -14% |
| 2025 | $36.0 | $36.6 | +1.4% |
| 2026 YTD | $36.6 | $50.8 | +39% |
CGNX is up 39% so far in 2026, after finishing lower in four of the previous six years.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over CGNX on returns for 2026, with the stronger performance.